Overlap between adverse events (AEs) and serious adverse events (SAEs): a case study of a phase III cancer clinical trial. (2020)

First Author: James EC
Attributed to:  Effective and efficient conduct of trials and meta-analyses funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/s13063-020-04718-z

PubMed Identifier: 32943106

Publication URI: http://europepmc.org/abstract/MED/32943106

Type: Journal Article/Review

Volume: 21

Parent Publication: Trials

Issue: 1

ISSN: 1745-6215